A new study from the University of Oxford has revealed a surprising benefit of the respiratory syncytial virus (RSV) vaccine: ...

The new RSV recommendation calls for a single dose of vaccine for adults age 50 to 59 years who are at increased risk of ...

The expanded recommendation is good news for Moderna, Pfizer, and GSK, which all sell RSV vaccines for older adults. Moderna ...

The U.S. Centers for Disease Control and Prevention has accepted recommendations made by a panel of vaccine experts in April, ...

The Trump administration appears to be expanding RSV vaccinations to some adults starting at age 50 instead of 60 ...

Last winter’s respiratory syncytial virus, or RSV, season wasn’t as brutal for U.S. babies. A new study suggests two preventive tools — a maternal vaccine and a monoclonal antibody for ...

RSV-associated hospitalizations for children aged 8-19 months or 20-59 months were not significantly different between the two time periods, and slightly higher in the 2024-2025 period.

RSV, or respiratory syncytial (sin-SISH-uhl) virus, is the leading cause of hospitalization for infants in the US. An estimated 58,000–80,000 children younger than 5 years old are hospitalized ...

Common RSV symptoms in many people include "a runny nose, cough, sneezing and fever – basically mild cold-like symptoms that are mostly contained to the upper respiratory tract," says Dr. Alison ...

Both colds and RSV have symptoms such as sneezing, runny nose, cough, sore throat, and decrease in appetite. Babies with RSV may be irritable, fatigued, and have breathing difficulties. A barking or ...

RSV is a common respiratory virus that causes mild, cold-like symptoms in healthy adults. Like similar viruses, it infects the nose, throat and lungs, making it difficult to tell apart from other ...

RSV is a common respiratory virus that usually causes mild, cold-like symptoms with most people recovering in a week or two. However, RSV is one of the most common causes of hospitalization in infants ...